Fabienne Krauer

Author PubWeight™ 12.05^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.	N Engl J Med	2010	4.36
2	Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.	Kidney Int	2008	1.84
3	Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.	Kidney Int	2010	1.77
4	Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.	PLoS One	2013	1.12
5	Soluble klotho and autosomal dominant polycystic kidney disease.	Clin J Am Soc Nephrol	2011	1.00
6	Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.	Am J Kidney Dis	2009	0.92
7	Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease.	Nephrol Dial Transplant	2009	0.83
8	Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial.	PLoS One	2012	0.78